193359-51-2 Usage
Uses
Used in Pharmaceutical Industry:
(2-Fluorophenyl)-4-pyridinyl-methanone is used as an intermediate in the manufacturing process of various drugs. Its unique chemical structure allows for the development of new pharmaceutical compounds with potential therapeutic applications.
Used in Agrochemical Industry:
(2-Fluorophenyl)-4-pyridinyl-methanone is used as an intermediate in the production of pesticides. Its chemical properties enable the creation of effective agrochemicals for pest control and crop protection.
Used in Organic Synthesis and Research:
(2-Fluorophenyl)-4-pyridinyl-methanone is used as a reagent in organic synthesis and research. Its versatility as a building block allows for the exploration of new chemical reactions and the development of novel compounds for various applications.
Overall, (2-Fluorophenyl)-4-pyridinyl-methanone is an important chemical intermediate with various industrial and research applications.
Check Digit Verification of cas no
The CAS Registry Mumber 193359-51-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,3,3,5 and 9 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 193359-51:
(8*1)+(7*9)+(6*3)+(5*3)+(4*5)+(3*9)+(2*5)+(1*1)=162
162 % 10 = 2
So 193359-51-2 is a valid CAS Registry Number.
InChI:InChI=1/C12H8FNO/c13-11-4-2-1-3-10(11)12(15)9-5-7-14-8-6-9/h1-8H
193359-51-2Relevant academic research and scientific papers
Photocatalyst-controlled and visible light-enabled selective oxidation of pyridinium salts
Peng, Xiang-Jun,He, Hai-Ping,Liu, Qian,She, Kun,Zhang, Bao-Qi,Wang, Heng-Shan,Tang, Hai-Tao,Pan, Ying-Ming
, p. 753 - 760 (2021/03/31)
This study proposes two different methods of photocatalytic-controlled and visible light-induced selective oxidation of pyridiniums with air as the terminal oxidant. The key to these transformations is to choose the appropriate light source and photocatal
4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists
-
, (2011/05/18)
PCT No. PCT/US96/20872 Sec. 371 Date Sep. 16, 1998 Sec. 102(e) Date Sep. 16, 1998 PCT Filed Dec. 20, 1996 PCT Pub. No. WO97/23216 PCT Pub. Date Jul. 3, 1997Novel 4-substituted piperidine analogs, pharmaceutical compositions containing the same and the method of using 4-substituted piperidine analogs are selective active antagonists of N-methyl-D-aspartate (NMDA) receptor subtypes for treating conditions such as stroke, cerebral ischemia, central nervous system trauma, hypoglycemia, psychosis, anxiety, migraine headaches, glaucoma, CMV retinitis, aminoglycoside antibiotics-induced hearing loss, convulsions, chronic pain, opioid tolerance or withdrawal, urinary incontinence or neurodegenerative disorders, such as lathyrism, Alzheimer's Disease, Parkinsonism and Huntington's Disease are described.
